NOVONIX Ltd Files Form 6-K
Ticker: NVNXF · Form: 6-K · Filed: Sep 3, 2024 · CIK: 1859795
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
Related Tickers: NVX
TL;DR
NOVONIX filed a 6-K, standard foreign private issuer update. Nothing major disclosed.
AI Summary
NOVONIX Limited filed a Form 6-K on September 3, 2024, reporting for the month of September 2024. The filing indicates that the company is a foreign private issuer and files annual reports under Form 20-F. The document includes an Exhibit Index with Appendix 2A.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding NOVONIX's status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine regulatory filing with no new material financial information or significant operational changes disclosed.
Key Players & Entities
- NOVONIX Limited (company) — Registrant
- 0000950170-24-102573 (accession_number) — Filing identifier
- 20240903 (date) — Filing date
- Form 6-K (document_type) — Filing type
- Form 20-F (document_type) — Annual report form
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide certain information that the issuer makes public in its home country or distributes to its security holders.
What is NOVONIX Limited's filing status?
NOVONIX Limited is identified as a foreign private issuer and files annual reports under cover of Form 20-F.
When was this Form 6-K filed?
This Form 6-K was filed on September 3, 2024.
What is included in the Exhibit Index of this filing?
The Exhibit Index lists Exhibit 99.1 as 'Appendix 2A'.
Does this filing indicate a submission in paper format?
No, the checkboxes for submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) and Rule 101(b)(7) are not checked.
Filing Stats: 224 words · 1 min read · ~1 pages · Grade level 12.8 · Accepted 2024-09-03 09:28:25
Filing Documents
- nvx-6k-sep-24-09-02-app2.htm (6-K) — 20KB
- nvx-ex99_1.htm (EX-99.1) — 100KB
- nvx-ex99_2.htm (EX-99.2) — 75KB
- nvx-ex99_3.htm (EX-99.3) — 53KB
- img58969013_0.jpg (GRAPHIC) — 1KB
- img59892534_0.jpg (GRAPHIC) — 1KB
- 0000950170-24-102573.txt ( ) — 253KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. NOVONIX LIMITED By: /s/ Dr. John Christopher Burns Dr. John Christopher Burns Chief Executive Officer Date: September 3, 2024